Validation of novel low-dose CT methods for quantifying bone marrow in the appendicular skeleton of patients with multiple myeloma: initial results from the [18F]FDG PET/CT sub-study of the Phase 3 GMMG-HD7 Trial
Christos Sachpekidis(Democritus University of Thrace), Antonia Dimitrakopoulou‐Strauss(German Cancer Research Center), Anna Jauch, Olof Enqvist(Chalmers University of Technology), Marina Hajiyianni(Heidelberg University), Ekaterina Menis(Heidelberg University), Alexander Brobeil(Heidelberg University), Stefan Delorme(German Cancer Research Center), Niels Weinhold(German Cancer Research Center), Hartmut Goldschmidt(Heidelberg University), Martin Grözinger(German Cancer Research Center), Marc S. Raab(Unknown), Annette Kopp‐Schneider(German Cancer Research Center), Sandra Sauer(Heidelberg University), Michael Hundemer(Heidelberg University), Johann M. E. Jende(German Cancer Research Center), Lukas John(University of Hohenheim), Lars Edenbrandt(Sahlgrenska University Hospital), Heinz‐Peter Schlemmer(German Cancer Research Center)
Cited by 4
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
|The Lancet Oncology|2019|493